083790 — CrystalGenomics Invites Co Share Price
0.000.00%
Last trade - 00:00- KR₩246bn
- KR₩230bn
- KR₩5bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.69 | ||
| Price to Tang. Book | 1.71 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 50.44 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -8.52% | ||
| Return on Equity | -28.24% | ||
| Operating Margin | -327.56% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 14,006.56 | 30,223.48 | 42,376.29 | 4,321.33 | 4,878.66 | n/a | n/a | -18.88% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CrystalGenomics Invites Co Ltd is a Korea-based company principally engaged in the development and manufacturing of pharmaceuticals. The Company operates through three segments. The fFinished Pharmaceuticals Manufacturing segment is engaged in the manufacture and sale of finished pharmaceuticals. The Pharmaceutical R&D Division is engaged in the provision of clinical trial analysis and technical services and the sale of new drugs. The segment also operates in the real estate leasing business. The Others segment engages in the manufacture and sale of hot fats and other household items.
Directors
- Jung Myeong Cho CEO (64)
- Sang Cheon Ahn MDR (50)
- Seong Su Goh DRC (62)
- Chang Hui Han DRC (57)
- Ho Jin Jang DRC (50)
- Ji Yong Jang DRC (73)
- Seong Gu Noh DRC (52)
- Ji Wung Song DRC
- Si Yeong Song NID (63)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 7th, 2000
- Public Since
- January 6th, 2006
- No. of Shareholders
- 26,862
- No. of Employees
- 64
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 76,543,443
- Address
- 5F, A tower, Korea Bio Park, SEONGNAM, 13488
- Web
- http://www.cgxinc.com/
- Phone
- +82 316282700
- Auditors
- Hyundai Accounting Co.
Upcoming Events for 083790
Q2 2024 CrystalGenomics Invites Co Ltd Earnings Release
Similar to 083790
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
Ahn-Gook Pharmaceutical Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
FAQ
What is the CrystalGenomics Invites Co share price?
As of Today at 19:06 UTC, shares in CrystalGenomics Invites Co are trading at KR₩3,215. This share price information is delayed by 15 minutes.
How has the CrystalGenomics Invites Co share price performed this year?
Shares in CrystalGenomics Invites Co last closed at KR₩3,215 and the price had moved by -9.41% over the past 365 days. In terms of relative price strength the CrystalGenomics Invites Co share price has underperformed the FTSE Developed Asia Pacific Index by -8.78% over the past year.
What are the analyst and broker recommendations for CrystalGenomics Invites Co?
There is no consensus recommendation for this security.
What is the CrystalGenomics Invites Co dividend yield?
CrystalGenomics Invites Co does not currently pay a dividend.
Does CrystalGenomics Invites Co pay a dividend?
CrystalGenomics Invites Co does not currently pay a dividend.
When does CrystalGenomics Invites Co next pay dividends?
CrystalGenomics Invites Co does not currently pay a dividend.
How do I buy CrystalGenomics Invites Co shares?
To buy shares in CrystalGenomics Invites Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of CrystalGenomics Invites Co?
As of the previous close price of KR₩3,215, shares in CrystalGenomics Invites Co had a market capitalisation of KR₩246bn.
Where are CrystalGenomics Invites Co shares listed?
Here are the trading details for CrystalGenomics Invites Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 083790
What kind of share is CrystalGenomics Invites Co?
Based on an overall assessment of its quality, value and momentum CrystalGenomics Invites Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a CrystalGenomics Invites Co share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the CrystalGenomics Invites Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CrystalGenomics Invites Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +4.07%.
As of the last closing price of KR₩3,215, shares in CrystalGenomics Invites Co were trading -0.7% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the CrystalGenomics Invites Co PE Ratio?
The CrystalGenomics Invites Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩3,215.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of CrystalGenomics Invites Co?
CrystalGenomics Invites Co's management team is headed by:
- Jung Myeong Cho - CEO
- Sang Cheon Ahn - MDR
- Seong Su Goh - DRC
- Chang Hui Han - DRC
- Ho Jin Jang - DRC
- Ji Yong Jang - DRC
- Seong Gu Noh - DRC
- Ji Wung Song - DRC
- Si Yeong Song - NID